URL Pharma, Inc. today announced the launch of the Colcrys® (colchicine, USP) Patient Assistance Program, an initiative that will allow work with limited means to save on Colcrys prescriptions. This program reflects URL Pharma's ongoing commitment to helping ensure that all public who rely on the company's medications are able to access them, unheeding of monetary status. Colcrys is indicated for the surcease and regimen of gout flares and for the regimen of Familial Mediterranean Fever (FMF).

More: - Continued here